Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation
NCT05504356 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1125
Last updated 2026-01-23
Summary
VIBRANT-AF seeks to:
* Identify clinically relevant predictors of effectiveness and complications of AF ablation procedures in a prospective, US-based, multi-center, real-world longitudinal study
* Assess changes in modifiable lifestyle-related exposures influence the effectiveness of AF ablation
* Determine incidence and predictors of complications of AF ablation procedures
Participants will connect with the Eureka Research Platform and answer a series of surveys and activities over a one-year period. They will be asked about lifestyle habits, recurrence of AFib, hospitalizations, and general feelings and emotions.
Conditions
Sponsors & Collaborators
-
American College of Cardiology
collaborator OTHER -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Gregory Marcus, MD, MAS · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-27
- Primary Completion
- 2026-07-31
- Completion
- 2027-07-31
Countries
- United States
Study Locations
More Related Trials
-
Atrial Fibrillation Ablation Pilot Study
NCT00744835 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System
NCT05120193 ·Status: COMPLETED ·Phase: NA
-
Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
NCT01056328 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Patients Undergoing Atrial Fibrillation Ablation
NCT03388333 ·Status: COMPLETED
-
Atrial Fibrillation Registry 2017
NCT05023590 ·Status: UNKNOWN ·Phase: NA
-
Health eHeart BEAT-AFib - Health eHeart Biomarkers of Early Atrial Transformation in Atrial Fibrillation
NCT04404465 ·Status: ENROLLING_BY_INVITATION
-
Noninvasive 3D Mapping in Persistent Atrial Fibrillation, to Describe Modifications of the Arrhythmogenic Substrate After Pulmonary Vein Isolation and Identify Potential Predicting Factors of Ablation Success
NCT04229160 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Noninvasive Mapping Before Surgical Ablation
NCT06803615 ·Status: ACTIVE_NOT_RECRUITING
-
Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial
NCT06931821 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Stanford Cardiac Invasive Electrophysiology Novel Computer Experience
NCT03549806 ·Status: COMPLETED
-
Abbott Atrial Fibrillation Post Approval Study
NCT05434650 ·Status: ACTIVE_NOT_RECRUITING
-
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
NCT06200311 ·Status: RECRUITING ·Phase: NA
-
AcQForce Pulsed Field Ablation-CE
NCT05113056 ·Status: COMPLETED ·Phase: NA
-
Therapy of Atrial Flutter by Afib Ablation
NCT02051621 ·Status: UNKNOWN ·Phase: NA
-
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
NCT03811795 ·Status: UNKNOWN ·Phase: NA
-
Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
NCT00729911 ·Status: COMPLETED ·Phase: PHASE4
-
Ablation STrategies for Repeat PrOcedures in Patients With Atrial Fibrillation Recurrences
NCT04056390 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
CONcomitant eValuation of Epicor Left atRial Therapy for AF
NCT00519194 ·Status: TERMINATED ·Phase: NA
-
Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs
NCT06740539 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Atrial Fibrillation Management in Congestive Heart Failure With Ablation
NCT00652522 ·Status: COMPLETED ·Phase: NA
-
Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
NCT04342312 ·Status: UNKNOWN
-
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
NCT01661205 ·Status: COMPLETED ·Phase: NA
-
Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence
NCT02150902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.
NCT04045639 ·Status: COMPLETED
-
Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab
NCT06719921 ·Status: ENROLLING_BY_INVITATION ·Phase: NA